TY - JOUR
T1 - Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients
T2 - the ECHOVID-19 study
AU - Lassen, Mats Christian Højbjerg
AU - Skaarup, Kristoffer Grundtvig
AU - Lind, Jannie Nørgaard
AU - Alhakak, Alia Saed
AU - Sengeløv, Morten
AU - Nielsen, Anne Bjerg
AU - Espersen, Caroline
AU - Ravnkilde, Kirstine
AU - Hauser, Raphael
AU - Schöps, Liv Borum
AU - Holt, Eva
AU - Johansen, Niklas Dyrby
AU - Modin, Daniel
AU - Djernaes, Kasper
AU - Graff, Claus
AU - Bundgaard, Henning
AU - Hassager, Christian
AU - Jabbari, Reza
AU - Carlsen, Jørn
AU - Lebech, Anne-Mette
AU - Kirk, Ole
AU - Bodtger, Uffe
AU - Lindholm, Matias Greve
AU - Joseph, Gowsini
AU - Wiese, Lothar
AU - Schiødt, Frank Vinholt
AU - Kristiansen, Ole Peter
AU - Walsted, Emil Schwarz
AU - Nielsen, Olav Wendelboe
AU - Madsen, Birgitte Lindegaard
AU - Tønder, Niels
AU - Benfield, Thomas
AU - Jeschke, Klaus Nielsen
AU - Ulrik, Charlotte Suppli
AU - Knop, Filip
AU - Lamberts, Morten
AU - Sivapalan, Pradeesh
AU - Gislason, Gunnar
AU - Marott, Jacob Louis
AU - Møgelvang, Rasmus
AU - Jensen, Gorm
AU - Schnohr, Peter
AU - Søgaard, Peter
AU - Solomon, Scott D
AU - Iversen, Kasper
AU - Jensen, Jens Ulrik Staehr
AU - Schou, Morten
AU - Biering-Sørensen, Tor
N1 - ©2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
PY - 2020/12
Y1 - 2020/12
N2 - AIMS: The present study had two aims: (i) compare echocardiographic parameters in COVID-19 patients with matched controls and (2) assess the prognostic value of measures of left (LV) and right ventricular (RV) function in relation to COVID-19 related death.METHODS AND RESULTS: In this prospective multicentre cohort study, 214 consecutive hospitalized COVID-19 patients underwent an echocardiographic examination (by pre-determined research protocol). All participants were successfully matched 1:1 with controls from the general population on age, sex, and hypertension. Mean age of the study sample was 69 years, and 55% were male participants. LV and RV systolic function was significantly reduced in COVID-19 cases as assessed by global longitudinal strain (GLS) (16.4% ± 4.3 vs. 18.5% ± 3.0, P < 0.001), tricuspid annular plane systolic excursion (TAPSE) (2.0 ± 0.4 vs. 2.6 ± 0.5, P < 0.001), and RV strain (19.8 ± 5.9 vs. 24.2 ± 6.5, P = 0.004). All parameters remained significantly reduced after adjusting for important cardiac risk factors. During follow-up (median: 40 days), 25 COVID-19 cases died. In multivariable Cox regression reduced TAPSE [hazard ratio (HR) = 1.18, 95% confidence interval (CI) [1.07-1.31], P = 0.002, per 1 mm decrease], RV strain (HR = 1.64, 95%CI[1.02;2.66], P = 0.043, per 1% decrease) and GLS (HR = 1.20, 95%CI[1.07-1.35], P = 0.002, per 1% decrease) were significantly associated with COVID-19-related death. TAPSE and GLS remained significantly associated with the outcome after restricting the analysis to patients without prevalent heart disease.CONCLUSIONS: RV and LV function are significantly impaired in hospitalized COVID-19 patients compared with matched controls. Furthermore, reduced TAPSE and GLS are independently associated with COVID-19-related death.
AB - AIMS: The present study had two aims: (i) compare echocardiographic parameters in COVID-19 patients with matched controls and (2) assess the prognostic value of measures of left (LV) and right ventricular (RV) function in relation to COVID-19 related death.METHODS AND RESULTS: In this prospective multicentre cohort study, 214 consecutive hospitalized COVID-19 patients underwent an echocardiographic examination (by pre-determined research protocol). All participants were successfully matched 1:1 with controls from the general population on age, sex, and hypertension. Mean age of the study sample was 69 years, and 55% were male participants. LV and RV systolic function was significantly reduced in COVID-19 cases as assessed by global longitudinal strain (GLS) (16.4% ± 4.3 vs. 18.5% ± 3.0, P < 0.001), tricuspid annular plane systolic excursion (TAPSE) (2.0 ± 0.4 vs. 2.6 ± 0.5, P < 0.001), and RV strain (19.8 ± 5.9 vs. 24.2 ± 6.5, P = 0.004). All parameters remained significantly reduced after adjusting for important cardiac risk factors. During follow-up (median: 40 days), 25 COVID-19 cases died. In multivariable Cox regression reduced TAPSE [hazard ratio (HR) = 1.18, 95% confidence interval (CI) [1.07-1.31], P = 0.002, per 1 mm decrease], RV strain (HR = 1.64, 95%CI[1.02;2.66], P = 0.043, per 1% decrease) and GLS (HR = 1.20, 95%CI[1.07-1.35], P = 0.002, per 1% decrease) were significantly associated with COVID-19-related death. TAPSE and GLS remained significantly associated with the outcome after restricting the analysis to patients without prevalent heart disease.CONCLUSIONS: RV and LV function are significantly impaired in hospitalized COVID-19 patients compared with matched controls. Furthermore, reduced TAPSE and GLS are independently associated with COVID-19-related death.
KW - COVID-19
KW - Echocardiography
KW - Global longitudinal strain
KW - Right ventricular strain
KW - SARS-CoV-2
U2 - 10.1002/ehf2.13044
DO - 10.1002/ehf2.13044
M3 - Journal article
C2 - 33089972
SN - 2055-5822
VL - 7
SP - 4189
EP - 4197
JO - ESC Heart Failure
JF - ESC Heart Failure
IS - 6
ER -